Medicines regulation in the MENA region and the importance of the World Health Organization’s INN proposal of Biological Qualifier

Author(s): Michael S Reilly, Esq, Peter J Pitts, BA

Author byline as per print journal: Peter J Pitts, BA; Michael S Reilly, Esq Abstract: The World Health Organization should finalize its Biological Qualifier guidance. Distinguishable naming will allow quick and accurate tracing of the manufacturer, should adverse events occur and improve patient safety by reducing confusion and mishaps. This will ensure that developing nations, including […]

Read more →